Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
USANA Health Sciences Inc is a household & personal products business based in the US. USANA Health Sciences shares (USNA) are listed on the NYSE and all prices are listed in US Dollars. USANA Health Sciences employs 1,943 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $98.58 |
|---|---|
| 52-week range | $80.00 - $107.85 |
| 50-day moving average | $101.12 |
| 200-day moving average | $98.90 |
| Wall St. target price | $104.00 |
| PE ratio | 15.4604 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $6.55 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $98.58 from 2022-01-20
| 1 week (2022-01-14) | -2.64% |
|---|---|
| 1 month (2021-12-21) | -2.53% |
| 3 months (2021-10-21) | -1.73% |
| 6 months (2021-07-21) | -2.73% |
| 1 year (2021-01-21) | 15.12% |
|---|---|
| 2 years (2020-01-21) | 22.57% |
| 3 years (2019-01-18) | 118.97 |
| 5 years (2017-01-20) | 59.77% |
Valuing USANA Health Sciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of USANA Health Sciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
USANA Health Sciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, USANA Health Sciences shares trade at around 15x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
USANA Health Sciences's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0695. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into USANA Health Sciences's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
USANA Health Sciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $204.2 million.
The EBITDA is a measure of a USANA Health Sciences's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $1.2 billion |
|---|---|
| Operating margin TTM | 15.55% |
| Gross profit TTM | $925.5 million |
| Return on assets TTM | 20.67% |
| Return on equity TTM | 34.46% |
| Profit margin | 11.05% |
| Book value | $20.31 |
| Market capitalisation | $2 billion |
TTM: trailing 12 months
We're not expecting USANA Health Sciences to pay a dividend over the next 12 months.
USANA Health Sciences's shares were split on a 2:1 basis on 22 November 2016. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your USANA Health Sciences shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for USANA Health Sciences shares which in turn could have impacted USANA Health Sciences's share price.
Over the last 12 months, USANA Health Sciences's shares have ranged in value from as little as $80 up to $107.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while USANA Health Sciences's is 0.8459. This would suggest that USANA Health Sciences's shares are less volatile than average (for this exchange).
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.